State Institute of Health & Family Welfare, Shimla 171009, Himachal Pradesh, India.
Directorate of Health, Kasumpti, Shimla 171009, Government of Himachal Pradesh, India.
Vaccine. 2019 Oct 3;37 Suppl 1:A128-A131. doi: 10.1016/j.vaccine.2019.07.087. Epub 2019 Aug 5.
Since 2008, we in Himachal Pradesh have used a "pooling strategy" to help patients save money by pooling vials of antirabies vaccine at a centralized hospital and sharing them using the intradermal technique. In 2014, there was an acute shortage of rabies immunoglobulins (RIG) and two patients died after four injections of rabies vaccine were administered without RIG, which was not commercially available. After an extensive literature review and technical and ethical committee clearances, in June 2014 we started to infiltrate equine RIG (eRIG) into wound/s only without the recommended systemic intramuscular (IM) injection. WHO recommended this technique in 2018. During the four-year period June 2014 to June 2018, 7506 of 10,830 patients exposed to suspected rabid animals were injected with eRIG in and around the wounds in a single clinic at DDU Hospital Shimla without any adverse outcomes. The average volume of eRIG used per patient was 0.75 mL and cost US$ 0.75. Of the 80% of patients who were followed up, all were healthy at the end of a year, including 26 patients bitten by laboratory-confirmed rabid dogs. The reaction rate after PEP administration also declined significantly. Since February 2018, Himachal has started following the new WHO recommendations on PEP regimens of three intradermal antirabies vaccines instead of four, thereby saving hundreds of vaccine vials that became useful during shortages of rabies vaccine in India. To date, more than 700 vaccine vials have been saved in a single clinic at DDU hospital during the past 6 months alone. Not giving PEP to patients who have consumed raw milk from a suspected rabid cow has also saved 62 vials. Currently, 90 "pooling centers" have been established for sharing of vaccine and eRIG vials in Himachal State, generating huge savings that have enabled the government to provide PEP free of charge to all. The new WHO guidelines are a positive step towards a rabies-free world by 2030.
自 2008 年以来,我们在喜马偕尔邦采用了一种“汇集策略”,即在一家中心医院汇集抗狂犬病疫苗小瓶,以帮助患者省钱,并使用皮内技术共享这些小瓶。2014 年,狂犬病免疫球蛋白 (RIG) 严重短缺,两名患者在接受四剂狂犬病疫苗注射后死亡,因为没有商业供应 RIG。在广泛的文献回顾和技术及伦理委员会批准后,我们于 2014 年 6 月开始仅将马源 RIG (eRIG) 注入伤口/周围,而不推荐系统肌内 (IM) 注射。世界卫生组织在 2018 年推荐了这种技术。在 2014 年 6 月至 2018 年的四年期间,在 Shimla 的 DDU 医院的一个单一诊所中,对 10830 名疑似接触过狂犬病动物的患者中的 7506 人在伤口周围和内部注射了 eRIG,没有任何不良后果。每位患者平均使用 eRIG 0.75 毫升,费用为 0.75 美元。在接受随访的 80%的患者中,所有患者在一年结束时都健康,包括 26 名被实验室确认的狂犬病犬咬伤的患者。PEP 给药后的反应率也显著下降。自 2018 年 2 月以来,喜马偕尔邦开始遵循世界卫生组织关于狂犬病疫苗的新 PEP 方案,即使用三种皮内狂犬病疫苗而非四种,从而节省了数百个在印度狂犬病疫苗短缺期间有用的疫苗小瓶。迄今为止,仅在过去 6 个月内,DDU 医院的一个单一诊所就节省了 700 多支疫苗。不给食用疑似狂犬病牛的生奶的患者接种 PEP 也节省了 62 支疫苗。目前,喜马偕尔邦已建立了 90 个“汇集中心”,用于共享疫苗和 eRIG 小瓶,从而节省了大量资金,使政府能够免费为所有人提供 PEP。新的世界卫生组织指南是朝着 2030 年无狂犬病世界迈出的积极一步。